RNA — Avidity Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Avidity Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	328	406	611	595	1,501
Net Total Accounts Receivable
Net Total Receivables	—	—	—	1.1	28.2
Prepaid Expenses
Total Other Current Assets
Total Current Assets	332	411	623	611	1,542
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.92	15.6	15	16.7	18.3
Other Long Term Assets
Total Assets	334	428	639	629	1,564
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.6	29.7	51.9	80.7	98
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	27.7	46.1	60.7	128	139
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	306	381	578	501	1,425
Total Liabilities & Shareholders' Equity	334	428	639	629	1,564
Total Common Shares Outstanding